AI Boosts Breast Cancer Detection in Landmark Swedish Trial
Landmark Swedish trial shows AI improves breast cancer detection by 9%, reduces interval cancers by 12%, signaling potential for global healthcare systems.
News & Insights Across Asia
Landmark Swedish trial shows AI improves breast cancer detection by 9%, reduces interval cancers by 12%, signaling potential for global healthcare systems.
OpenAI and Ant Group introduce AI-driven healthcare solutions, enhancing global access to medical information while addressing privacy and reliability concerns.
On ALS Awareness Day, groundbreaking research from Asian institutions brings new hope in the fight against ALS, highlighting the role of advanced technology and AI in developing potential treatments.